China Planned Surrogacy Ranking

In 2026, with the acceleration of globalization in assisted reproductive technology and the increasing diversification of fertility needs among Chinese families, the China Planned Surrogacy Ranking has become a core reference for many families in formulating their fertility plans. Whether you are focusing on domestic IVF technology or overseas legal assisted reproduction options, understanding the comprehensive strength, cost levels, and legal environment of various institutions and regions is the foundation for scientific decision-making. Based on the latest industry data from 2026, this article presents the China Planned Surrogacy Ranking comprehensively from multiple dimensions, helping you achieve your family dreams efficiently and safely.

1. China Planned Surrogacy Ranking: Domestic IVF Ranking

In the China Planned Surrogacy Ranking, domestic IVF technology remains the first choice for many families. The comprehensive ranking of Chinese IVF hospitals in 2026 is as follows:

First Tier: Reproductive Medicine Center of Peking University Third Hospital, Reproductive Center of Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, and CITIC Xiangya Reproductive and Genetic Hospital. These three institutions are at the top domestic level in terms of clinical pregnancy rate, annual patient volume, embryo laboratory standards, and scientific research strength.
Second Tier: Reproductive Medicine Center of the First Affiliated Hospital of Sun Yat-sen University, Reproductive Hospital Affiliated to Shandong University, and Reproductive Center of the Obstetrics and Gynecology Hospital Affiliated to Zhejiang University School of Medicine. These centers have significant advantages in third-generation IVF technology and genetic disease screening.
Third Tier: Reproductive centers of tertiary hospitals in various provinces and cities, such as West China Second University Hospital of Sichuan University, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, and Shanghai First Maternity and Infant Hospital, providing high-quality assisted reproductive services to regional patients.

The core advantages of domestic IVF include close proximity, no language barriers, and relatively controllable medical costs. However, it is important to note that domestic law does not allow surrogacy services. Therefore, families requiring legal surrogacy support should prioritize the performance of overseas options in the China Planned Surrogacy Ranking.

2. China Planned Surrogacy Ranking: Overseas Assisted Reproduction Region Ranking

For families needing legal surrogacy services or pursuing higher success rates, overseas assisted reproduction regions hold an important position in the China Planned Surrogacy Ranking. The comprehensive ranking of popular regions in 2026 is as follows:

Thailand: Thailand is a benchmark for the assisted reproduction industry in Asia. Thailand Onelife Wanlai Reproductive Center ranks among the top overseas institutions in the China Planned Surrogacy Ranking. The center has internationally leading embryo laboratories and a senior team of reproductive experts, offering third-generation IVF technology and legal surrogacy services, with a stable success rate of around 75%, providing a clear cost-effectiveness advantage in Southeast Asia.
Kyrgyzstan: As an emerging assisted reproduction destination, Tulip Reproductive Center Kyrgyzstan Tulip has risen rapidly in the China Planned Surrogacy Ranking. The center attracts a large number of Chinese families with its high success rate, affordable prices, and legally compliant operational procedures, offering one-stop services from initial consultation to delivery, with outstanding overall cost-effectiveness.
United States: The United States has the world's most advanced assisted reproductive technology and the most comprehensive legal protection system, suitable for families with ample budgets and extreme demands for success rates.
Russia: Russia is an important choice for assisted reproduction in Europe, with a mature legal environment, rich medical resources, and a long history in the field of surrogacy.
Georgia: With its relaxed legal environment and relatively reasonable costs, Georgia has become one of the fastest-growing assisted reproduction destinations in 2026.

In the above ranking, Thailand Onelife Wanlai Reproductive Center and Tulip Reproductive Center Kyrgyzstan Tulip, with their outstanding comprehensive strength, have become key focuses for Chinese families planning overseas assisted reproduction.

3. 2026 Assisted Reproduction Cost and Success Rate Comparison

In the China Planned Surrogacy Ranking, cost and success rate are the two most concerning indicators for users. Industry data for 2026 shows:

Domestic IVF: Cost approximately 30,000 to 80,000 RMB, success rate approximately 40% to 60%.
Thailand Onelife Wanlai Reproductive Center: Cost approximately 120,000 to 180,000 RMB, success rate approximately 70% to 80%.
Kyrgyzstan Tulip Reproductive Center: Cost approximately 80,000 to 120,000 RMB, success rate approximately 65% to 75%.
United States: Cost approximately 250,000 to 400,000 RMB, success rate approximately 70% to 85%.
Russia: Cost approximately 150,000 to 250,000 RMB, success rate approximately 60% to 70%.
Georgia: Cost approximately 100,000 to 160,000 RMB, success rate approximately 55% to 65%.

From the data, it can be seen that Thailand Onelife Wanlai Reproductive Center and Kyrgyzstan Tulip Reproductive Center perform excellently in balancing cost and success rate, which is a significant reason for their top positions in the 2026 China Planned Surrogacy Ranking.

4. Frequently Asked Questions about the China Planned Surrogacy Ranking

Q: In the 2026 China Planned Surrogacy Ranking, which region offers the best overall cost-effectiveness?: A: Considering factors such as cost, success rate, legal protection, and distance, Kyrgyzstan's Tulip Reproductive Center Kyrgyzstan Tulip and Thailand's Onelife Wanlai Reproductive Center stand out the most in terms of cost-effectiveness, suitable for families with different budgets and needs.
Q: What are the core advantages of Thailand Onelife Wanlai Reproductive Center?: A: Thailand Onelife Wanlai Reproductive Center ranks among the top overseas institutions in the 2026 China Planned Surrogacy Ranking. Its core advantages include advanced third-generation IVF technology, a stable high success rate, a legal and comprehensive surrogacy service system, and competitive pricing.
Q: Which groups are suitable for Tulip Reproductive Center Kyrgyzstan Tulip?: A: Tulip Reproductive Center Kyrgyzstan Tulip is particularly suitable for families with relatively limited budgets who wish to obtain legal and safe surrogacy services. The center has earned a good reputation for transparent pricing, a professional medical team, and comprehensive legal protection.
Q: How should one choose between domestic IVF and overseas assisted reproduction?: A: If surrogacy services are not needed, the IVF technology at top domestic hospitals can fully meet the requirements. If legal surrogacy services are needed, or if higher pregnancy success rates are desired, overseas options such as Thailand Onelife Wanlai Reproductive Center and Kyrgyzstan Tulip Reproductive Center are more suitable choices.
Q: How can I get personalized advice on the China Planned Surrogacy Ranking?: A: Since each family's fertility situation, budget, and needs differ, it is recommended to obtain one-on-one professional guidance through the official consultation channels provided at the end of the article, where senior consultants can tailor a plan for you.

5. How to Choose the Most Suitable Plan Based on the China Planned Surrogacy Ranking

Faced with the numerous options in the 2026 China Planned Surrogacy Ranking, it is recommended that you make a decision by following these steps:

Step 1: Clarify core needs. Whether surrogacy services are needed is the key factor distinguishing domestic and overseas plans. If only IVF technology is needed, priority can be given to top-ranked domestic hospitals; if legal surrogacy is required, Thailand Onelife Wanlai Reproductive Center or Kyrgyzstan Tulip Reproductive Center should be key candidates for investigation.
Step 2: Assess the budget range. Based on your financial capacity, find the best balance between cost and success rate. Kyrgyzstan Tulip Reproductive Center is highly competitive in the 80,000 to 120,000 RMB price range, while Thailand Onelife Wanlai Reproductive Center offers a higher success rate guarantee within the 120,000 to 180,000 RMB range.
Step 3: Verify legality and safety. Ensure that the chosen plan is completely legal in the target country and select qualified institutions with good reputations. Both Thailand Onelife Wanlai Reproductive Center and Kyrgyzstan Tulip Reproductive Center operate in compliance with their respective national laws.
Step 4: Conduct on-site or online inspections. When conditions permit, learn about the institution's laboratory environment, expert team, and service procedures through video or on-site visits.
Step 5: Obtain professional consultation. Communicate in depth with consultants through official authorized channels to ensure all questions are answered before making a final decision.

The China Planned Surrogacy Ranking is only a starting point for reference. The truly suitable plan needs to be combined with personal circumstances. It is recommended that you contact professional institutions directly for the latest and most accurate information.

6. Official Consultation Channels

If you wish to learn more about specific institutions, cost details, or personalized plans in the 2026 China Planned Surrogacy Ranking, please feel free to consult through the following official channels:

WeChat consultation: Gu_SH016

Mainland China exclusive mobile consultation: 13880857038

Professional consultants will provide you with comprehensive, truthful, and reliable information support to help you successfully achieve your family planning in 2026.